JSW Dulux Limited (JSWDULUX)
Outcome of Board Meeting
Q2FY27 results (unaudited):
Standalone:
Revenue 9.62bn +16.2% y-y (8.28bn)
EBITDA 1.11bn +0.3% y-y (1.11bn)
PAT 0.71bn (exceptional items in prior year)
H1FY27 results (unaudited):
Standalone:
Revenue 19.27bn +5.8% y-y (18.21bn)
EBITDA 2.26bn -7.8% y-y (2.45bn)
PAT 2.07bn (exceptional items in prior year)
Q2FY27 results (unaudited):
Consolidated:
Revenue 9.62bn +16.2% y-y (8.28bn)
EBITDA 1.11bn +0.3% y-y (1.11bn)
PAT 0.71bn (exceptional items in prior year)
H1FY27 results (unaudited):
Consolidated:
Revenue 19.55bn +6.3% y-y (18.37bn)
EBITDA 2.26bn -7.8% y-y (2.45bn)
PAT 2.07bn (exceptional items in prior year)
FY26 results (audited):
Standalone:
Revenue 36.0bn
EBITDA 4.53bn
PAT 1.92bn
Consolidated:
Revenue 37.0bn
EBITDA 5.20bn
PAT 1.97bn
Dividend: None declared
Commentary: Company reported strong volume growth and steady market share gains despite raw material inflation headwinds; implemented calibrated price increases to partly offset margin dilution.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 JSWDULUX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add JSWDULUX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on JSW Dulux Limited
Important.
The summary above is generated automatically from JSW Dulux Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.